• Home
  • Myelodysplastic Syndrome

Myelodysplastic Syndrome

Image placeholder title
Myelodysplastic Syndrome

Stem Cell Transplant - Successful Treatment for Myelodysplastic Syndromes

Image placeholder title
Myelodysplastic Syndrome

Magrolimab Anti-CD47 Monoclonal Antibody

Myelodysplastic Syndrome MDS
Myelodysplastic Syndrome

Overview of Myelodysplastic Syndrome

Image placeholder title
Myelodysplastic Syndrome

Inqovi (cedazuridine) Treatment for Myelodysplastic Syndromes and CMML

Image placeholder title
Myelodysplastic Syndrome

Dacogen™ Effective in Myelodysplastic Syndromes

Image placeholder title
Myelodysplastic Syndrome

Reblozyl® Approved to Treat Anemia for Lower-Risk Myelodysplastic Syndromes

Myelodysplastic Syndrome MDS
Myelodysplastic Syndrome

Treatment of Myelodysplastic Syndrome

Image placeholder title
Myelodysplastic Syndrome

Guadecitabine Treatment for Myelodysplastic Syndromes

Image placeholder title
Myelodysplastic Syndrome

The CancerConnect Myelodysplastic Syndrome Newsletter

Image placeholder title
Myelodysplastic Syndrome

Revlimid® Reduces Need for Blood Transfusions in Some Myelodysplastic Syndromes

Image placeholder title
Myelodysplastic Syndrome

Novel Agent may Reverse Resistance to Targeted Therapy in Acute Leukemia and MDS

Image placeholder title
Myelodysplastic Syndrome

Vidaza® Improves Survival in Higher-risk Myelodysplastic Syndromes

Image placeholder title
Myelodysplastic Syndrome

Vidaza® Approved for High-risk MDS

Image placeholder title
Myelodysplastic Syndrome

Vidaza Improves Survival in High-risk Myelodysplastic Syndrome

Image placeholder title
Myelodysplastic Syndrome

Mylotarg® and Vidaza® Effective for Elderly Patients with AML or MDS

Image placeholder title
Myelodysplastic Syndrome

Revlimid® Shows Promise in Treatment of Myelofibrosis with Myeloid Metaplasia

Image placeholder title
Myelodysplastic Syndrome

Updates in the Management of Myelodysplastic Syndromes

Image placeholder title
Myelodysplastic Syndrome

Vidaza® Improves Survival in Myelodysplastic Syndromes

Image placeholder title
Myelodysplastic Syndrome

Revlimid® Effective for Patients with Myelodysplastic Syndromes with Deletion

Image placeholder title
Myelodysplastic Syndrome

AMG 531 May Be Effective in Treating Thrombocytopenia in Patients with MDS

Image placeholder title
Myelodysplastic Syndrome

Erythropoietin Plus Granulocyte Macrophage Factor for Myelodysplastic Syndrome

Image placeholder title
Myelodysplastic Syndrome

Anti-Inflammatory Drug Combination Appears to Improve Blood Counts for Persons

Image placeholder title
Myelodysplastic Syndrome

Aggressive Chemotherapy Increases Remission in Patients with High-Risk MDS

Image placeholder title
Myelodysplastic Syndrome

Autologous Stem Cell Transplants Prove Promising in Myelodysplastic Syndromes

Image placeholder title
Myelodysplastic Syndrome

Further Evidence that Vidaza® Reduces Need for Transfusions in MDS

Image placeholder title
Myelodysplastic Syndrome

Revlimid® Approved for Myelodysplastic Syndromes

Image placeholder title
Myelodysplastic Syndrome

Thalidomide Effective for Myelodysplastic Syndrome

Image placeholder title
Myelodysplastic Syndrome

Revlimid™ Effective for Low-Risk Myelodysplastic Syndromes

Image placeholder title
Myelodysplastic Syndrome

Prospective Study Shows Age Doesn’t Affect Survival Outcomes in Patients

Image placeholder title
Myelodysplastic Syndrome

Prolonged Erythropoietin Appears More Effective Than Short Course for MDS

Image placeholder title
Myelodysplastic Syndrome

Revlimid® Shows Promise for Myelodysplastic Syndromes

Image placeholder title
Myelodysplastic Syndrome

Thalidomide Promising for Myelodysplastic Syndromes